5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 1.21▼ | 1.21▼ | 1.21▼ | 1.25▼ | 1.25▼ |
MA10 | 1.22▼ | 1.24▼ | 1.24▼ | 1.26▼ | 1.26▼ |
MA20 | 1.25▼ | 1.27▼ | 1.27▼ | 1.26▼ | 1.51▼ |
MA50 | 1.29▼ | 1.28▼ | 1.26▼ | 1.26▼ | 4.57▼ |
MA100 | 1.29▼ | 1.26▼ | 1.27▼ | 1.69▼ | 13.21▼ |
MA200 | 1.26▼ | 1.28▼ | 1.37▼ | 4.03▼ | 190.44▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.005▼ | -0.009▼ | -0.010▼ | 0.001▲ | 0.231▲ |
RSI | 28.773▼ | 35.076▼ | 37.574▼ | 43.275▼ | 31.950▼ |
STOCH | 8.333▼ | 7.222▼ | 7.222▼ | 49.910 | 37.497 |
WILL %R | -100.000▼ | -100.000▼ | -100.000▼ | -60.314 | -76.190▼ |
CCI | -110.914▼ | -134.123▼ | -139.103▼ | -78.894 | -46.193 |
Tuesday, June 10, 2025 06:02 AM
Enveric Biosciences (NASDAQ: ENVB) ("Enveric" or the "Company"), a biotechnology company advancing next-generation neuroplastogenic small molecules to address psychiatric and neurological disorders, ...
|
Wednesday, June 04, 2025 01:20 PM
Enveric Biosciences, Inc. (NASDAQ:ENVB) has obtained U.S. Patent No. 12,187,679 for a new family of hydroxylated psilocybin derivatives that selectively bind to the melatonin MT1 receptor. The patent ...
|
Tuesday, June 03, 2025 05:59 AM
Enveric Biosciences (NASDAQ: ENVB) ("Enveric" or the "Company"), a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
13/06/25 | 1.21 | 1.22 | 1.18 | 1.21 | 100,804 |
12/06/25 | 1.24 | 1.26 | 1.21 | 1.24 | 63,805 |
11/06/25 | 1.24 | 1.3097 | 1.23 | 1.23 | 136,787 |
10/06/25 | 1.27 | 1.28 | 1.225 | 1.28 | 774,671 |
09/06/25 | 1.31 | 1.36 | 1.30 | 1.30 | 122,550 |
06/06/25 | 1.27 | 1.3286 | 1.26 | 1.30 | 67,104 |
05/06/25 | 1.28 | 1.34 | 1.25 | 1.26 | 169,973 |
04/06/25 | 1.26 | 1.31 | 1.23 | 1.29 | 120,654 |
03/06/25 | 1.29 | 1.33 | 1.2092 | 1.27 | 515,468 |
02/06/25 | 1.19 | 1.26 | 1.19 | 1.23 | 149,717 |
|
|
||||
|
|
||||
|
|